Evidence map›Paper›PMID 36449624›Full record

ArticleScience advances2022

The SARS-CoV-2 spike protein binds and modulates estrogen receptors.

Oscar Solis, Andrea R Beccari, Daniela Iaconis, Carmine Talarico, Camilo A Ruiz-Bedoya, Jerome C Nwachukwu, Annamaria Cimini, Vanessa Castelli, Riccardo Bertini, Monica Montopoli and 21 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 10 institutions in 3 countries.

Oscar SolisBiobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA.ORCID 0000-0002-8285-5891
Andrea R BeccariEXSCALATE, Dompé farmaceutici S.p.A, Napoli, Italy.ORCID 0000-0001-6830-2695
Daniela IaconisEXSCALATE, Dompé farmaceutici S.p.A, Napoli, Italy.ORCID 0000-0002-1052-6634
Carmine TalaricoEXSCALATE, Dompé farmaceutici S.p.A, Napoli, Italy.ORCID 0000-0003-4789-0955
Camilo A Ruiz-BedoyaCenter for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0002-0653-4244
Jerome C NwachukwuDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.ORCID 0000-0003-4313-9187
Annamaria CiminiDepartment of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Vanessa CastelliDepartment of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.ORCID 0000-0002-7005-3218
Riccardo BertiniAtreius S.a.s., L'Aquila, Italy.
Monica MontopoliDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Veronica CocettaDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.ORCID 0000-0002-0350-8403
Stefano BorocciDepartment for Innovation in Biological, Agro-Food and Forest Systems, DIBAF, University of Tuscia, Viterbo, Italy.
Ingrid G PrandiDepartment for Innovation in Biological, Agro-Food and Forest Systems, DIBAF, University of Tuscia, Viterbo, Italy.ORCID 0000-0002-3253-1821
Kelly FlavahanCenter for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Melissa BahrCenter for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0002-0278-000X
Anna NapiorkowskiCenter for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0002-8937-0926
Giovanni ChillemiDepartment for Innovation in Biological, Agro-Food and Forest Systems, DIBAF, University of Tuscia, Viterbo, Italy.ORCID 0000-0003-3901-6926
Masato OokaDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, Rockville, MD 20850, USA.ORCID 0000-0002-2729-2619
Xiaoping YangDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0003-1263-2710
Shiliang ZhangNeuronal Networks Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA.ORCID 0000-0001-8414-6178
Menghang XiaDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, Rockville, MD 20850, USA.ORCID 0000-0001-7285-8469
Wei ZhengDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, Rockville, MD 20850, USA.ORCID 0000-0003-1034-0757
Jordi BonaventuraDepartament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L'Hospitalet de Llobregat, Catalonia, Spain.ORCID 0000-0002-4745-0151
Martin G PomperDepartment of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0001-6753-3010
Jody E HooperDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0002-8209-3559
Marisela MoralesNeuronal Networks Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA.
Avi Z RosenbergDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0003-2356-950X
Kendall W NettlesDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.
Sanjay K JainCenter for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0001-9620-7070
Marcello AllegrettiDompé farmaceutici S.p.A, L'Aquila, Italy.ORCID 0000-0002-0617-0233
Michael MichaelidesBiobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA.ORCID 0000-0003-0398-4917
Johns Hopkins University · USDompé (Italy) · ITNational Institute on Drug Abuse · USNational Center for Advancing Translational Sciences · USUniversità degli Studi della Tuscia · ITScripps Research Institute · USUniversity of L'Aquila · ITUniversity of Padua · ITStanford University · USUniversitat de Barcelona · ES

Funding

Drug Repurposing Screening for Rare and Neglected DiseasesZIATR000018 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI ZHENG, WEI · 2015 to 2025
$24.6M
Training/Dissemination-Resource for Molecular Imaging Agents in Precision MedicineP41EB024495 · NIBIB · UT SOUTHWESTERN MEDICAL CENTER · PI MARTIN G POMPER · 2017 to 2026
$11.8M
Measuring Intralesional Drug Exposures in Cavitary TB using Noninvasive In Vivo PET ImagingR01AI153349 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JAIN, SANJAY · 2020 to 2024
$3.8M
ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.R01AI161829 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DESAI, TEJAL A., FLAVELL, ROBERT RICHARD · 2021 to 2023
$2.4M
NIAID NIH HHS R01 AI153349NIAID NIH HHS R01 AI161829NIBIB NIH HHS P41 EB024495
6 · The paper itself

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein binds angiotensin-converting enzyme 2 as its primary infection mechanism. Interactions between S and endogenous proteins occur after infection but are not well understood. We profiled binding of S against >9000 human proteins and found an interaction between S and human estrogen receptor α (ERα). Using bioinformatics, supercomputing, and experimental assays, we identified a highly conserved and functional nuclear receptor coregulator (NRC) LXD-like motif on the S2 subunit. In cultured cells, S DNA transfection increased ERα cytoplasmic accumulation, and S treatment induced ER-dependent biological effects. Non-invasive imaging in SARS-CoV-2-infected hamsters localized lung pathology with increased ERα lung levels. Postmortem lung experiments from infected hamsters and humans confirmed an increase in cytoplasmic ERα and its colocalization with S in alveolar macrophages. These findings describe the discovery of a S-ERα interaction, imply a role for S as an NRC, and advance knowledge of SARS-CoV-2 biology and coronavirus disease 2019 pathology.

Indexed as

COVID-19Spike Glycoprotein, CoronavirusAnimalsCricetinaeEstrogen Receptor alphaHumansReceptors, EstrogenSARS-CoV-2Estrogen Receptor alphaReceptors, EstrogenSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID36449624
PMCPMC9710872
OpenAlexW4310437636

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.